While gephyrin exonic microdeletions and missense mutations are associated with autism, schizophrenia, and epilepsy in humans [40–42], whether gephyrin phosphorylation is relevant for the establishment of inhibition during postnatal sensitive periods has not been examined. Here, GPHN is linked to autism.